Efficacy of the anti–IL-6 receptor antibody tocilizumab in neuromyelitis optica: A pilot study

OBJECTIVE: To evaluate the safety and efficacy of a humanized anti–interleukin-6 receptor antibody, tocilizumab (TCZ), in patients with neuromyelitis optica (NMO). METHODS: Seven patients with anti–aquaporin-4 antibody (AQP4-Ab)-positive NMO or NMO spectrum disorders were recruited on the basis of t...

Descripción completa

Detalles Bibliográficos
Autores principales: Araki, Manabu, Matsuoka, Takako, Miyamoto, Katsuichi, Kusunoki, Susumu, Okamoto, Tomoko, Murata, Miho, Miyake, Sachiko, Aranami, Toshimasa, Yamamura, Takashi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2014
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4001188/
https://www.ncbi.nlm.nih.gov/pubmed/24634453
http://dx.doi.org/10.1212/WNL.0000000000000317

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4001188/
https://www.ncbi.nlm.nih.gov/pubmed/24634453
http://dx.doi.org/10.1212/WNL.0000000000000317

Ejemplares similares